Jennifer Buell Highlights Strategic Partnership Between Agenus and Zydus
Jennifer Buell, Director Board of Directors at Agenus, shared a post on LinkedIn:
“Proud to share that Agenus and Zydus Group Lifesciences have entered a $141M strategic collaboration to advance BOT/BAL and expand U.S.-based biologics manufacturing.
Highlights:
- $75M upfront for exclusive cutting-edge manufacturing facilities and team
- Up to $50M in contingent payments tied to BOT/BAL production
- $16M investment in Agenus at $7.50/share
- Royalties on BOT/BAL in 🇮🇳 India and Sri Lanka
Zydus gains exclusive access to our state-of-the-art facilities and world-class manufacturing team—true leaders in precision biologics production. We gain a trusted partner with global scale, operational excellence, and deep commitment to patient access.
To our Emeryville and Berkeley teams: Your excellence has built a foundation for U.S.–India trade and global health impact. You now anchor a flagship CDMO footprint and the next chapter of cancer immunotherapy delivery.
This collaboration not only secures our ability to deliver BOT/BAL globally—it also reflects the broader U.S. commitment to strengthening domestic biomanufacturing and deepening trusted international partnerships.
We are aligning with the trade and supply chain priorities of Howard W. Lutnick, Jamieson Greer, Scott Bessent, U.S. Department of State, Pentagon, US Department of Defense, Office of the Secretary of Defense for Policy to reinforce America’s leadership in global biotech and its role in shaping resilient, high-integrity supply chains.
Proud to see our manufacturing excellence—driven by Dr. Al Dadson and our Emeryville and Berkeley teams—serve as a cornerstone of that vision.”
More posts featuring Agenus
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023